US2007190551A1PendingUtilityA1
Non-alloying core shell nanoparticles
Est. expiryMay 25, 2021(expired)· nominal 20-yr term from priority
B22F 1/17B22F 1/10B22F 1/18B22F 1/102H10D 62/814Y10T428/12083B82Y 30/00C12Q 1/6816C01G 7/00G01N 33/5434B22F 9/24C01P 2002/82G01N 33/588C01G 49/08G01N 33/54393G01N 33/553C12Q 1/6834C12Q 1/6813B22F 2998/00B82Y 25/00H01F 1/0054B82Y 10/00G01N 33/543C01P 2004/84C01G 11/02B82Y 5/00A61K 49/0093C01P 2004/04C01P 2006/42C01B 19/007B82Y 15/00C01P 2004/64A61K 49/0067
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates composite core/shell nanoparticles and a two-step method for their preparation. The present invention further relates to biomolecule-core/shell nanoparticle conjugates and methods for their preparation. The invention also relates to methods of detection of biomolecules comprising the biomolecule-core/shell nanoparticle conjugates.
Claims
exact text as granted — not AI-modified1 . An core/shell nanoparticle comprising:
(a) an inner metal-containing nanoparticle core; and (b) an outer non-alloying gold shell surrounding the nanoparticle core.
2 . A core/shell nanoparticle oligonucleotide conjugate comprising:
(a) an inner metal-containing nanoparticle core; (b) an outer non-alloying gold shell surrounding the nanoparticle core; and (c) oligonucleotides attached to the gold shell.
3 . The core/shell nanoparticle of claim 2 wherein the oligonucleotides have a sequence complementary to a portion of a sequence of a target nucleic acid.
4 . The core/shell nanoparticle of claims 1 or 2 , wherein the inner metal containing nanoparticle core comprises silver, Pt, Fe, Co, or Ni.
5 . The core/shell nanoparticle of claims 1 or 2 , wherein the inner metallic nanoparticle core comprises an alloy metal comprising FePt or FeAu.
6 . The core/shell nanoparticle of claims 1 or 2 wherein the inner metal-containing nanoparticle core comprises a metal oxide.
7 . The core/shell nanoparticle of claims 1 or 2 , wherein the inner metal-containing nanoparticle core is magnetic.
8 . The core/shell nanoparticle of claim 6 wherein the inner metal-containing nanoparticle core comprises Fe 3 O 4 or CO 3 O 4 .
9 . The core/shell nanoparticle of claims 1 or 2 , wherein the inner metal-containing nanoparticle core comprises a semiconductor.
10 . The core/shell nanoparticle of claim 9 , wherein the inner metal-containing nanoparticle core comprises CdSe or CdS.
11 . The core/shell nanoparticle of claims 1 or 2 , wherein the gold shell ranges from about 0.5 to about 2 monolayers in thickness.
12 . The core/shell nanoparticle of claim 2 wherein the oligonucleotides are attached to the nanoparticles in a stepwise ageing process comprising (i) contacting the oligonucleotides with the nanoparticles in a first aqueous solution for a period of time sufficient to allow some of the oligonucleotides to bind to the nanoparticles; (ii) adding at least one salt to the aqueous solution to create a second aqueous solution; and (iii) contacting the oligonucleotides and nanoparticles in the second aqueous solution for an additional period of time to enable additional oligonucleotides to bind to the nanoparticles;
13 . The core/shell nanoparticle of claim 12 wherein the oligonucleotides include a moiety comprising a functional group which can bind to a nanoparticle.
14 . The core/shell nanoparticle of claim 12 wherein all of the salt is added to the water in a single addition.
15 . The core/shell nanoparticle of claim 12 wherein the salt is added gradually over time.
16 . The core/shell nanoparticle of claim 12 wherein the salt is selected from the group consisting of sodium chloride, magnesium chloride, potassium chloride, ammonium chloride, sodium acetate, ammonium acetate, a combination of two or more of these salts, one of these salts in a phosphate buffer, and a combination of two or more these salts in a phosphate buffer.
17 . The core/shell nanoparticle of claim 16 wherein the salt is sodium chloride in a phosphate buffer.
18 . The core/shell nanoparticle of claim 12 wherein nanoparticle-oligonucleotide conjugates are produced which have the oligonucleotides present on surface of the nanoparticles at a surface density of at least 10 picomoles/cm 2 .
19 . The core/shell nanoparticle of claim 18 wherein the oligonucleotides are present on surface of the nanoparticles at a surface density of at least 15 picomoles/cm 2 .
20 . The core/shell nanoparticle of claim 19 wherein the oligonucleotides are present on surface of the nanoparticles at a surface density of from about 15 picomoles/cm 2 to about 40 picomoles/cm 2 .
21 . A nanostructure comprising the core/shell nanoparticles of claims 1 or 2 .
22 . A silver/gold core/shell nanoparticle comprising:
(a) an inner silver nanoparticle core; and (b) an outer non-alloying gold shell surrounding the nanoparticle core.
23 . A magnetic core/shell nanoparticle comprising:
(a) an inner Fe 3 O 4 nanoparticle core; and (b) an outer non-alloying gold shell surrounding the nanoparticle core.
24 . A semiconductor core/shell nanoparticle comprising:
(a) an inner semiconductor nanoparticle core; and (b) an outer non-alloying gold shell surrounding the nanoparticle core.
25 . The semiconductor core/shell nanoparticle of claim 24 , wherein the inner nanoparticle core comprises CdSe or CdS.
26 . The core/shell nanoparticle oligonucleotide conjugate of any of claims 1 , 2 or 22 wherein the surface plasmon absorption peak is at about 500 to 530 nm.
27 . (canceled)
28 . (canceled)
29 . (canceled)
30 . (canceled)
31 . (canceled)
32 . (canceled)
33 . (canceled)
34 . (canceled)
35 . (canceled)
36 . (canceled)
37 . (canceled)
38 . (canceled)Join the waitlist — get patent alerts
Track US2007190551A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.